expert perspectives

Expert Perspectives in Multiple Myeloma to Cover Key Topics in Multiple Myeloma Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives in Multiple Myeloma will feature community-selected experts and topics that we hope you will find of value in your clinical practice.


VIEW THE TOPICS

Expert Roundtables 

  • Durability of Response With Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
  • Minimal Residual Disease Testing for Tailored Treatment in Multiple Myeloma
  • Newer Options in the Management of Triple-Class Refractory Multiple Myeloma
  • The Emerging Competitive Landscape in Relapsed/Refractory Multiple Myeloma


Clinical Topic Updates 

  • Current and Future Roles of Autologous Stem Cell Transplantation in Multiple Myeloma
  • Management and Mitigation Strategies for Late-Onset Immune Effector Cell–Related Neurotoxicity
  • Multiple Myeloma: High-Risk, Ultra High-Risk, and Extramedullary Disease in Focus
  • Newer Treatments and Sequencing Questions in Relapsed/Refractory Multiple Myeloma


Patient Care Perspectives 

  • Addressing Individual Patient Needs in the Shifting Multiple Myeloma Paradigm
  • Bridging Therapy Prior to Chimeric Antigen Receptor T-Cell Therapy in Patients With Multiple Myeloma
  • Comorbidities and Candidacy for Chimeric Antigen Receptor T-Cell Therapy vs Autologous Stem Cell Transplantation
  • Discussing the Journey: Educating and Preparing Patients for Chimeric Antigen Receptor T-Cell Therapy

More in Multiple Myeloma

Thumb

Multiple Myeloma

Clinical Recommendations for the Treatment of Elderly or Frail Patients With Multiple Myeloma

Patient Care Perspectives by Carol Ann Huff, MD

Optimizing the care of older patients with multiple myeloma involves striking a balance between efficacy and toxicity. It also involves a deep unde...READ MORE

Thumb

Multiple Myeloma

Treatment Protocols for Patients With Multiple Myeloma Who Relapse After Transplant

Clinical Topic Updates by James R. Berenson, MD

While most patients with multiple myeloma will achieve disease control with autologous stem cell transplant (ASCT), virtually all of these individu...READ MORE

Thumb

Multiple Myeloma

Quality of Life and Supportive Care for Patients With Multiple Myeloma

Patient Care Perspectives by James R. Berenson, MD

Owing to significant bone pain, vulnerability to infection, fatigue, and other symptomatology related—and unrelated—to multiple myeloma, the diseas...READ MORE

More In Oncology

cGVHD

Chronic Graft-versus-Host Disease: Biomarkers, Mediators, and Druggable Targets

Clinical Topic Updates by David Miklos, MD, PhD

cGVHD

Evolving Transplant Technology and Chronic Graft-versus-Host Disease

Patient Care Perspectives by Edmund K. Waller, MD, PhD, FACP

cGVHD

Advancements in the Management of Chronic Graft-versus-Host Disease

Expert Roundtables by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and Edmund K. Waller, MD, PhD, FACP